Pfizer Inc. buy Truist Financial Co.
Start price
04.12.23
/
50%
€27.35
Target price
04.12.24
€38.83
Performance (%)
-12.49%
End price
05.12.24
€23.94
Summary
This prediction ended on 05.12.24 with a price of €23.94. The price of Pfizer Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.49%. Truist_Financial_Co_ has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Dividends of €1.56 are taken into consideration when calculating the performance. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -0.252% | -0.252% | -9.607% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $42.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten